Completed NA INTERVENTIONAL 3-arm NCT04539314

Unilateral Transversus Abdominis Plane Block in Pediatrics

Dexmedetomidine as an Adjuvant to Bupivacaine in Unilateral Transversus Abdominis Plane Block in Pediatrics

Sponsor: Minia University

Conditions Unilateral TAP Block in Pediatric Patients Undergoing Lower Abdominal Surgery

Interventions Bupivacain Dexmedetomidine 1 μg Dexmedetomidine o.5 μg

Updated 6 times since 2020 Last updated: Jul 29, 2023 Started: Aug 1, 2019 Primary completion: Dec 26, 2020 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04539314, this NA trial focuses on Unilateral TAP Block in Pediatric Patients Undergoing Lower Abdominal Surgery and remains completed. Sponsored by Minia University, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2023 — Sep 2023 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Jan 2023 [monthly]

Recruiting NA

▶ Show 1 earlier version

Oct 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Aug 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Minia University

Data source: Minia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt